Pinealon (Glu-Asp-Arg): Tripeptide Bioregulator and Gene Expression Research
Origins: The Khavinson Bioregulator Program
Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (glutamic acid–aspartic acid–arginine, MW ~404 Da) developed as part of a decades-long research program at the Saint Petersburg Institute of Bioregulation and Gerontology under the direction of Professor Vladimir Khavinson. Beginning in the 1970s–80s, Khavinson's group systematically extracted short peptides from various mammalian tissues and characterized their biological activities, hypothesizing that tissue-specific short peptides could serve as epigenetic regulators of gene expression. Pinealon was derived from pineal gland tissue extracts.
The broader Khavinson bioregulator concept proposes that short peptides (2–4 amino acids) can interact directly with DNA regulatory sequences in a tissue-specific manner, modulating gene expression without acting through classical membrane receptor signaling. This mechanism—termed "peptide bioregulation"—remains an active area of investigation and debate in the peptide biology literature.
Chemical Structure
Pinealon is one of the smallest bioactive peptides studied in the literature. Its structure consists of:
- Glutamic acid (Glu): negatively charged at physiological pH, carboxylate side chain
- Aspartic acid (Asp): negatively charged, shorter carboxylate side chain
- Arginine (Arg): positively charged guanidinium group, capable of hydrogen bonding with DNA bases
The overall charge distribution (negative-negative-positive) and the presence of arginine's guanidinium group—known to interact with the DNA minor groove and phosphate backbone—are proposed as the structural basis for Pinealon's putative DNA-binding activity.
Published Research
Gene Expression Modulation
Studies from the Khavinson laboratory have reported that Pinealon modulates expression of specific gene clusters in neuronal cell cultures, including genes involved in cell differentiation, signal transduction, and apoptosis regulation. Microarray and RT-PCR analyses have been used to characterize these expression changes.
DNA Interaction Studies
Molecular modeling and in vitro binding assays have investigated the interaction between short peptides (including Glu-Asp-Arg) and double-stranded DNA. The proposed mechanism involves binding to the minor groove of specific DNA sequences, potentially influencing transcription factor accessibility.
Neuroendocrine Tissue Studies
As a pineal-derived bioregulator, Pinealon has been investigated in pinealocyte and neuronal cell culture models examining melatonin synthesis pathway enzymes (AANAT, HIOMT) and circadian clock gene expression.
Future Research Directions
The peptide bioregulation field remains in its early stages of validation by the broader scientific community. Key research needs include independent replication of DNA-binding studies using biophysical techniques (SPR, ITC, crystallography), genome-wide characterization of transcriptional effects using RNA-seq in standardized cell models, and mechanistic studies distinguishing direct DNA binding from indirect signaling effects.
Available at Crush Research: Pinealon 10mg. View Certificates of Analysis.
All products are intended for in vitro and laboratory research use only. Not for human or veterinary use.